Pfizer/BioNTech seek approval for new COVID boosters for children
Pfizer Inc and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration’s authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through 11 years. The application comes just days after Moderna (NASDAQ:MRNA) also applied for FDA authorization of its own Omicron-targeting shot in adolescents aged 12 to 17 years and children aged […]
Pfizer/BioNTech seek approval for new COVID boosters for children Read More »